Honliv Healthcare Management Group Company Limited
HKEX:9906.HK
2.3 (HKD) • At close October 30, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Revenue
| 760.527 | 727.789 | 606.837 | 524.043 | 531.108 | 496.551 | 478.924 |
| Cost of Revenue
| 615.683 | 589.394 | 471.531 | 386.451 | 360.952 | 336.585 | 319.294 |
| Gross Profit
| 144.844 | 138.395 | 135.306 | 137.592 | 170.156 | 159.966 | 159.63 |
| Gross Profit Ratio
| 0.19 | 0.19 | 0.223 | 0.263 | 0.32 | 0.322 | 0.333 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 72.393 | 73.345 | 68.545 | 71.199 | 21.286 | 6.716 | 6.687 |
| Selling & Marketing Expenses
| 15.734 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 72.393 | 73.345 | 68.545 | 71.199 | 21.286 | 6.716 | 6.687 |
| Other Expenses
| -0.197 | -0.421 | -0.556 | -0.244 | 52.596 | 0.178 | 0.157 |
| Operating Expenses
| 71.908 | 72.924 | 67.989 | 70.955 | 73.882 | 48.923 | 45.908 |
| Operating Income
| 57.445 | 61.561 | 66.561 | 61.97 | 96.481 | 111.649 | 113.862 |
| Operating Income Ratio
| 0.076 | 0.085 | 0.11 | 0.118 | 0.182 | 0.225 | 0.238 |
| Total Other Income Expenses Net
| -6.04 | 1.46 | -16.019 | -31.117 | -28.002 | -12.571 | -17.779 |
| Income Before Tax
| 51.422 | 63.021 | 50.542 | 30.853 | 68.479 | 98.472 | 95.943 |
| Income Before Tax Ratio
| 0.068 | 0.087 | 0.083 | 0.059 | 0.129 | 0.198 | 0.2 |
| Income Tax Expense
| 12.724 | 13.678 | 13.524 | 8.662 | 18.621 | 25.008 | 24.224 |
| Net Income
| 38.31 | 48.947 | 36.615 | 21.84 | 49.362 | 72.727 | 71.001 |
| Net Income Ratio
| 0.05 | 0.067 | 0.06 | 0.042 | 0.093 | 0.146 | 0.148 |
| EPS
| 0.066 | 0.08 | 0.06 | 0.04 | 0.082 | 0.12 | 0.12 |
| EPS Diluted
| 0.066 | 0.08 | 0.06 | 0.04 | 0.082 | 0.12 | 0.12 |
| EBITDA
| 134.6 | 129.091 | 98.343 | 84.046 | 116.235 | 135.346 | 140.1 |
| EBITDA Ratio
| 0.177 | 0.177 | 0.162 | 0.16 | 0.219 | 0.273 | 0.293 |